GT Biopharma Inc (GTBP)
4.98
-0.62
(-11.07%)
USD |
NASDAQ |
May 22, 14:19
GT Biopharma Total Assets (Quarterly): 9.912M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 9.912M |
| December 31, 2023 | 14.11M |
| September 30, 2023 | 16.15M |
| June 30, 2023 | 18.14M |
| March 31, 2023 | 20.09M |
| December 31, 2022 | 16.74M |
| September 30, 2022 | 21.07M |
| June 30, 2022 | 24.17M |
| March 31, 2022 | 27.44M |
| December 31, 2021 | 32.17M |
| September 30, 2021 | 35.80M |
| June 30, 2021 | 39.57M |
| March 31, 2021 | 27.64M |
| December 31, 2020 | 5.661M |
| September 30, 2020 | 0.917M |
| June 30, 2020 | 1.063M |
| March 31, 2020 | 0.295M |
| December 31, 2019 | 0.396M |
| September 30, 2019 | 0.482M |
| June 30, 2019 | 25.71M |
| March 31, 2019 | 25.54M |
| December 31, 2018 | 25.40M |
| September 30, 2018 | 26.54M |
| June 30, 2018 | 255.01M |
| March 31, 2018 | 257.33M |
| Date | Value |
|---|---|
| December 31, 2017 | 254.37M |
| September 30, 2017 | 256.52M |
| June 30, 2017 | 0.042M |
| March 31, 2017 | 0.238M |
| December 31, 2016 | 0.025M |
| September 30, 2016 | 0.16M |
| June 30, 2016 | 0.362M |
| March 31, 2016 | 0.037M |
| December 31, 2015 | 0.054M |
| September 30, 2015 | 0.049M |
| June 30, 2015 | 0.132M |
| March 31, 2015 | 1.425M |
| December 31, 2014 | 0.888M |
| September 30, 2014 | 0.71M |
| June 30, 2014 | 0.052M |
| March 31, 2014 | 0.103M |
| December 31, 2013 | 0.147M |
| September 30, 2013 | 0.062M |
| June 30, 2013 | 0.154M |
| March 31, 2013 | 0.118M |
| December 31, 2012 | 0.226M |
| September 30, 2012 | 0.088M |
| June 30, 2012 | 0.125M |
| March 31, 2012 | 0.166M |
| December 31, 2011 | 0.129M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.295M
Minimum
Mar 2020
39.57M
Maximum
Jun 2021
16.88M
Average
17.44M
Median
Total Assets (Quarterly) Benchmarks
| Cutera Inc | 311.99M |
| Outlook Therapeutics Inc | 59.03M |
| 180 Life Sciences Corp | 3.442M |
| Journey Medical Corp | 66.57M |
| NovaBay Pharmaceuticals Inc | 5.357M |